Literature DB >> 7868243

Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis.

E Candolfi1, C A Hunter, J S Remington.   

Abstract

Suppressed splenocyte proliferation in response to mitogen and toxoplasma lysate antigen (TLA) is observed in mice acutely infected with Toxoplasma gondii. Recently, we reported that NG-monomethyl-L-arginine (NMMA), an inhibitor of reactive nitrogen intermediate (RNI) production, partially restored proliferative responses of splenocytes from infected mice. In the present study we have examined the effect of NMMA on production of cytokines by splenocytes from mice acutely infected with T. gondii and assessed the role of gamma interferon (IFN-gamma) and interleukin-10 (IL-10) in the RNI-mediated suppression. Stimulation with concanavalin A (ConA) or TLA of splenocytes from CBA/Ca mice infected for 7 days resulted in increased production of IFN-gamma, IL-4, and IL-10 but reduced levels of IL-2 when compared with cultures of splenocytes from uninfected mice. Whereas addition of NMMA did not alter levels of cytokines produced by splenocytes from uninfected mice, splenocytes from infected mice stimulated with ConA produced significantly higher levels of IL-10 and reduced levels of IL-2 and IL-4. Addition of anti-IFN-gamma monoclonal antibodies to cultures of spleen cells from mice infected for 7 or 14 days remarkably decreased the levels of nitrite and resulted in a 47- and 4-fold increase in proliferation induced by stimulation with ConA or TLA, respectively. Anti-IL-10 did not reduce levels of nitrite produced in culture but did result in a fourfold increase in the proliferative response of splenocytes from mice infected for 14 days. In vivo administration of anti-IFN-gamma or anti-IL-10 monoclonal antibodies to infected mice partially restored ex vivo spleen cell proliferative responses by approximately 40 and 15%, respectively. Our data indicate that IFN-gamma is important in inducing the RNI-mediated immunosuppression, which, in turn, affects production of cytokines by splenocytes. Our data also demonstrate that IL-10 is involved in the suppression observed but that this activity is independent of RNI.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868243      PMCID: PMC173066          DOI: 10.1128/iai.63.3.751-756.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Effect of Toxoplasma gondii on the thymus.

Authors:  G Huldt; S Gard; S G Olovson
Journal:  Nature       Date:  1973-08-03       Impact factor: 49.962

2.  Studies on the regulation of lymphocyte reactivity by normal and activated macrophages.

Authors:  E J Wing; J S Remington
Journal:  Cell Immunol       Date:  1977-04       Impact factor: 4.868

3.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

Authors:  L C Green; D A Wagner; J Glogowski; P L Skipper; J S Wishnok; S R Tannenbaum
Journal:  Anal Biochem       Date:  1982-10       Impact factor: 3.365

4.  Role of lymphocyte blastogenesis to Toxoplasma gondii antigens in containment of chronic, latent T. gondii infection in humans.

Authors:  R McLeod; R G Estes
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

5.  Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis.

Authors:  B J Luft; G Kansas; E G Engleman; J S Remington
Journal:  J Infect Dis       Date:  1984-11       Impact factor: 5.226

6.  Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis.

Authors:  C A Hunter; M J Litton; J S Remington; J S Abrams
Journal:  J Infect Dis       Date:  1994-10       Impact factor: 5.226

7.  Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.

Authors:  S D Sharma; J Mullenax; F G Araujo; H A Erlich; J S Remington
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

8.  Demonstration of T-cell dysfunction during acute toxoplasma infection.

Authors:  J Chan; J P Siegel; B J Luft
Journal:  Cell Immunol       Date:  1986-04-01       Impact factor: 4.868

9.  Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi.

Authors:  A Harel-Bellan; M Joskowicz; D Fradelizi; H Eisen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Nonspecific suppression of primary antibody responses and presence of plastic-adherent suppressor cells in Toxoplasma gondii-infected mice.

Authors:  Y Suzuki; N Watanabe; A Kobayashi
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

View more
  21 in total

1.  Loss of IL-27Rα Results in Enhanced Tubulointerstitial Fibrosis Associated with Elevated Th17 Responses.

Authors:  Gaia M Coppock; Lillian R Aronson; Jihwan Park; Chengxiang Qiu; Jeongho Park; Jonathan H DeLong; Enrico Radaelli; Katalin Suszták; Christopher A Hunter
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum.

Authors:  Harry D Dawson; Ethiopia Beshah; Sandra Nishi; Gloria Solano-Aguilar; Motoko Morimoto; Aiping Zhao; Kathleen B Madden; Tonya K Ledbetter; J P Dubey; Terez Shea-Donohue; Joan K Lunney; Joseph F Urban
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection.

Authors:  W J Dai; B Gottstein
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

5.  Role of gamma interferon in cellular immune response against murine Encephalitozoon cuniculi infection.

Authors:  I A Khan; M Moretto
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis.

Authors:  G Reichmann; W Walker; E N Villegas; L Craig; G Cai; J Alexander; C A Hunter
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  Biological response modifier activity of an exopolysaccharide from Paenibacillus jamilae CP-7.

Authors:  A Ruiz-Bravo; M Jimenez-Valera; E Moreno; V Guerra; A Ramos-Cormenzana
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

8.  Different roles for interleukin-4 during the course of Toxoplasma gondii infection.

Authors:  C W Roberts; D J Ferguson; H Jebbari; A Satoskar; H Bluethmann; J Alexander
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

9.  Both expansion of regulatory GR1+ CD11b+ myeloid cells and anergy of T lymphocytes participate in hyporesponsiveness of the lung-associated immune system during acute toxoplasmosis.

Authors:  Mathieu-Benoît Voisin; Dominique Buzoni-Gatel; Daniel Bout; Florence Velge-Roussel
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

10.  Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.

Authors:  F G Araujo; T Slifer
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.